MRNA Trade on Sep 30, 2020 14:28 from beno: Tradervue User Stock Trades.

Fundamentals

N/a

Catalysts / News / Painting the picture

-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
-Jun 03 2020: MRNA in top 5 pick for vaccine candidate
-Jul 13 2020: MRNA to join NASDAQ 100 Index
-Jul 23 2020: Lost nano particle patent against ABUS, vaccine could be in jeopardy
-Sep 30 2020: MRNA vaccine was deemed safe / CEO says vaccine won't be ready before elections (End of November)

Technical Analysis

-SPY pattern: Mountain
-Intraday pattern: Parabolic Fade
-Other notes: N/a

Strategy / Confluence / Sizing Guide / Risk

Strategy: First test short of 72 level
Confluence: Whole $
Strike Zone: 71.75 - 72.25
Sizing (lots + emergency): 300
Risk (stop / Rs): Hold above 72.5

Review / Lessons Learned

Only had starter before it started dumping